Vitalik Buterin: Selling $30M ETH for Ethereum Foundation and Types of Research

The founder of Ethereum has actively donated a significant portion of his digital assets to support important institutions and types of research focused on the future of technology and biomedicine. Over the past month and early this year, Vitalik Buterin has conducted strategic transactions totaling over $30 million, which Arkham Intelligence reports as part of a long-term goal of philanthropy and ecosystem development.

The strategy of transferring ETH and reducing holdings

On-chain data from Arkham Intelligence shows that Buterin sold 17,196 ETH recently, valued at approximately $35 million based on a transaction price of $2,040. This sale reduced his ETH holdings from over 240,000 at the start of the year to about 224,000 ETH—roughly a seven percent decrease of his current holdings.

Notably, these holdings are very large compared to his historical holdings. In 2015, Buterin held about 663,000 ETH, meaning his balance has decreased by more than six percent over the past decade. However, Arkham reports that these reductions reflect his long-term commitments to ecosystem development rather than personal spending. Even with the decrease, he still maintains assets worth around $450 million in ETH and wrapped ETH, including positions in the Aave lending protocol.

Where did the $30 million go: blockchain transactions supporting research

Detailed transaction tracking provides clarity on how Buterin manages asset swaps for charitable and research purposes. On January 30, Arkham created a detailed record of a large transaction—selling 16,384 ETH, which was recorded on the blockchain days after settlement. The transaction originated from a Gnosis Safe Proxy wallet, a multi-signature solution used for secure fund management.

On February 2, Buterin conducted another transaction via CoW Protocol, a decentralized exchange protocol. The transaction converted 211.841 wrapped ETH through Wintermute, a well-known market maker. The result was exactly 500,000 USDC sent directly to Kanro’s wallet—an open-source biomedical research nonprofit founded by Buterin, dedicated to advancing open-source biomedical research and addressing existential risks in science and technology.

Kanro focuses on various research areas aimed at solving critical health and environmental challenges. The organization supports projects beyond traditional biotech, including basic science research and applied studies with potential to transform the industry.

Long-term pattern of charitable giving and research funding

Buterin’s ETH sales are not political acts but part of a broader pattern of his commitment to philanthropy and ecosystem development. In January 2025, he sold a collection of meme tokens and donated $2.5 million to Kanro, demonstrating consistency in his approach to fund allocation. In 2021, Buterin donated a substantial $1.2 billion worth of SHIB tokens to COVID relief efforts in India, showing his willingness to use digital assets for global humanitarian needs.

Arkham data supports the interpretation that these recent transactions follow a strategic giving pattern. During a period when Buterin mentioned “mild austerity” for the Ethereum Foundation—an era of prudent spending while strengthening the ecosystem—his ETH sales targeted two critical areas: institutional support for the Ethereum Foundation and direct funding for research aligned with Buterin’s vision of a more sustainable and responsible future.

This pattern reflects a holistic approach to wealth management that combines personal financial stewardship, ecosystem support, and commitment to scientific progress. As Ethereum’s price continues to fall below $2,000 in current market conditions, Buterin’s strategic sales serve as a testament to his confidence in the long-term value of the ecosystem and his dedication to building infrastructure for research vital to the future of technology and biomedicine.

ETH5.35%
AAVE4.8%
SHIB7.18%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin